Indonesia to sell carbon credits to conserve forests
Indonesia has applied to join a World Bank programme intended to help developing nations fight deforestation by selling tradeable carbon credits.
International climate negotiators are working to allow developing nations the right to sell some carbon credits if they clamp down on deforestation, which is responsible for roughly 20% of global greenhouse-gas emissions. The World Bank's US$300-million Forest Carbon Partnership Facility is designed to lay the groundwork for such an international agreement.
The programme already includes 25 countries, but Indonesia, the world's third-largest greenhouse-gas emitter, had remained on the sidelines until it applied in Feburary. The bank estimates that the country could earn between US$400 million and $2 billion selling credits for protecting forests.
Drug maker found liable despite FDA warning label
Drug makers can be held liable for harm caused by their medicines, even if the drugs already carry federally approved warning labels, the US Supreme Court ruled on 4 March. The high court majority said that Diana Levine was entitled to a US$6.7-million award a state jury gave her, after she sued drug maker Wyeth of New Jersey.
A musician from Vermont, Levine had a Wyeth anti-nausea drug mistakenly injected into an artery, even though a label, approved by the US Food and Drug Administration (FDA), warned against such practice. Gangrene set in, and Levine's forearm was amputated.
The ruling means that FDA labels do not protect companies from liability in state courts, where they are often sued. It could affect many businesses that have sought increased federal regulation as a shield for liability. In an effort to pursue joint Mars missions, ESA and NASA are looking at ways to get the MSO and ExoMars, a €1.2-billion (US$1.5-billion) rover also slated for a 2016 launch, on the same rocket.
